Your browser doesn't support javascript.
loading
Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.
Frenkel, Moshe; Sapire, Kenneth.
Afiliação
  • Frenkel M; Department of Family Medicine, The University of Texas Medical Branch at Galveston, Galveston, TX, USA. frenkelm@netvision.net.il.
  • Sapire K; Integrative Medicine Program, Institute of Oncology, Meir Medical Center, Kfar Saba, Israel. frenkelm@netvision.net.il.
Curr Oncol Rep ; 19(12): 79, 2017 Oct 14.
Article em En | MEDLINE | ID: mdl-29032389
Hematologic malignancies represent 9.7% of all cancers, making them the fourth most common type of cancer in the United States. The aggressive and complex treatments administered in hematologic malignancies result in a high burden of psychological needs. Complementary and integrative medicine (CIM) is becoming one of the options that patients use to address their distress during and after cancer treatments. It is not clear whether appropriate CIM can relieve distress in patients affected by these malignancies. This review covers the potential benefits of CIM as relates to nutrition, nutritional supplements, exercise, circadian rhythm, methods for reducing distress during bone marrow aspiration, massage therapy, and acupuncture, in treating patients with hematological malignancies. This review may provide a framework to enhance patient-doctor dialogue regarding CIM use in hematologic malignancies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapias Complementares / Neoplasias Hematológicas / Medicina Integrativa Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapias Complementares / Neoplasias Hematológicas / Medicina Integrativa Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2017 Tipo de documento: Article